NL-OMON25030
Not yet recruiting
Not Applicable
Reducing relapse and recurrence in depression with continuation Cognitive Therapy: A randomized controlled trial.
Arkin, mental health care institute Amsterdam,Department of Psychology of the University of Groningen,Vanderbilt University, Nashville,Vrije Universiteit Amsterdam, Faculteit der Geneeskunde Huisarts- en Verpleeghuisgeneeskunde,Trimbos Instituut, Innovation Centre of Mental Health & Technology,Vrije Universiteit Amsterdam, Faculteit der Aard- en Levenswetenschappen Gezondheidswetenschappen: Health Economics and Technology Assessment0 sites214 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Recurrence or Relapse of Major Depression Disorder
- Sponsor
- Arkin, mental health care institute Amsterdam,Department of Psychology of the University of Groningen,Vanderbilt University, Nashville,Vrije Universiteit Amsterdam, Faculteit der Geneeskunde Huisarts- en Verpleeghuisgeneeskunde,Trimbos Instituut, Innovation Centre of Mental Health & Technology,Vrije Universiteit Amsterdam, Faculteit der Aard- en Levenswetenschappen Gezondheidswetenschappen: Health Economics and Technology Assessment
- Enrollment
- 214
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Two or more previous depressive episodes indicating high risk for relapse/recurrence;
- •2\. In remission according to DSM\-IV criteria;
Exclusion Criteria
- •1\. Current mania or hypomania or a history of bipolar illness;
- •2\. Any psychotic disorder (current and previous);
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Reducing relapse and recurrence in depression with continuation Cognitive Therapy: a randomized controlled trial.depressive disorderdepression10027946NL-OMON40027Arkin (Amsterdam)214
Active, not recruiting
Phase 4
Antidepressants to prevent relapse in depression in older people aged 75 years and overDepressionMental and Behavioural DisordersISRCTN26190474niversity College London430
Active, not recruiting
Phase 1
Relapse prevention in patients with major depression treated with electroconvulsive therapy using a fixed dose range of escitalopram compared to a fixed dose of nortriptyline (DUAG-7)A randomised controlled 6 month double-blind study - Relapse prevention with escitalopram or nortriptyline following ECT (DUAG-7)EUCTR2008-003877-42-DKDanish University Antidepressant Group (DUAG)300
Completed
Not Applicable
Trial platform: preventing depression relapse in the National Health Service practice using Mindfulness-Based Cognitive TherapyISRCTN12720810niversity of Exeter (UK)80
Active, not recruiting
Not Applicable
Preventing relapse of major depressive disorder in youth: Randomised Controlled Trial of a novel mindfulness-based cognitive online social therapyACTRN12619001412123Orygen246